SCIENTIFIC EVIDENCE

Rational Design and Organoid-Based Evaluation of a Cocktail CAR-γδ T Cell Therapy for Heterogeneous Glioblastoma.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Zhu G, Sun Z, Liu Y, Liu J, Guo L, Pei G, Jiang Y, Miao B, Li Z, Zhang P, Tang D, Zhang W, Wang C.

Publication Overview

Key findings, Countstar context, and access to the original paper.
2025
3D Culture
Cancer Research
Immunology
Organoid Culture
Single-Cell Analysis
No items found.
Key Finding
The term "prof" cocktail therapy is coined to describe the approach using precise and rational combination of tumor antigens, organoid-based evaluation, and fitness of Vδ1 T cells. It may accelerate development of effective CAR-T drugs for heterogeneous solid tumors.
Countstar Connection
Researchers relied on Countstar (model not specified) for cell-count and viability measurements in the study's cell samples before single-cell analysis in the 2025 Advanced science study.
View paper ↗
Stay Connected toCountstar Science
Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.
Meet us online
Products
About Us
Contact
© 2026 Countstar. All rights reserved.